CN103717571B - 9-氨基甲基取代的四环素类化合物 - Google Patents
9-氨基甲基取代的四环素类化合物 Download PDFInfo
- Publication number
- CN103717571B CN103717571B CN201280037036.6A CN201280037036A CN103717571B CN 103717571 B CN103717571 B CN 103717571B CN 201280037036 A CN201280037036 A CN 201280037036A CN 103717571 B CN103717571 B CN 103717571B
- Authority
- CN
- China
- Prior art keywords
- compound
- alkyl
- base
- unit
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C*(C)N1CC(CC2)C2C1 Chemical compound C*(C)N1CC(CC2)C2C1 0.000 description 3
- ODSNARDHJFFSRH-UHFFFAOYSA-O C1[NH2+]CC2C1CCCC2 Chemical compound C1[NH2+]CC2C1CCCC2 ODSNARDHJFFSRH-UHFFFAOYSA-O 0.000 description 1
- UKVCZCZNTKQCCW-UHFFFAOYSA-N CC(C)(C)OC(NC(C1)CC1=C)=O Chemical compound CC(C)(C)OC(NC(C1)CC1=C)=O UKVCZCZNTKQCCW-UHFFFAOYSA-N 0.000 description 1
- FNHPTFKSPUTESA-UHFFFAOYSA-N CC(C)(C)OC(NC(C1)CC1=O)=O Chemical compound CC(C)(C)OC(NC(C1)CC1=O)=O FNHPTFKSPUTESA-UHFFFAOYSA-N 0.000 description 1
- MCPRXSXYXHMCKF-UHFFFAOYSA-N CC1(CN)COC1 Chemical compound CC1(CN)COC1 MCPRXSXYXHMCKF-UHFFFAOYSA-N 0.000 description 1
- SBEROSHQCHPJIB-UHFFFAOYSA-N CC1(CNC)COC1 Chemical compound CC1(CNC)COC1 SBEROSHQCHPJIB-UHFFFAOYSA-N 0.000 description 1
- OBAXRSXTJUNZRQ-UHFFFAOYSA-N CN1CC(C2)C2C1 Chemical compound CN1CC(C2)C2C1 OBAXRSXTJUNZRQ-UHFFFAOYSA-N 0.000 description 1
- HULIQIFSWBOHTE-UHFFFAOYSA-N CN1CC(CCC2)C2C1 Chemical compound CN1CC(CCC2)C2C1 HULIQIFSWBOHTE-UHFFFAOYSA-N 0.000 description 1
- QIJZCLCCTDBHEC-UHFFFAOYSA-N CN1CCC2(CC2)CC1 Chemical compound CN1CCC2(CC2)CC1 QIJZCLCCTDBHEC-UHFFFAOYSA-N 0.000 description 1
- ZYKWABRWFBVPIJ-UHFFFAOYSA-N FC(C1)CN1C(c1ccccc1)c1ccccc1 Chemical compound FC(C1)CN1C(c1ccccc1)c1ccccc1 ZYKWABRWFBVPIJ-UHFFFAOYSA-N 0.000 description 1
- NLAVRAPORLSNRM-UHFFFAOYSA-N NCC(CCC1=O)CC1(N)Cl Chemical compound NCC(CCC1=O)CC1(N)Cl NLAVRAPORLSNRM-UHFFFAOYSA-N 0.000 description 1
- SFMPCMROGBOIDW-UHFFFAOYSA-N NCN1C(C2)C2CC1 Chemical compound NCN1C(C2)C2CC1 SFMPCMROGBOIDW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/66—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems and singly-bound oxygen atoms, bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/40—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing six carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201280037036.6A CN103717571B8 (zh) | 2011-07-26 | 2012-07-26 | 9‑氨基甲基取代的四环素类化合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110222016.3 | 2011-07-26 | ||
CN201110222016 | 2011-07-26 | ||
CN201280037036.6A CN103717571B8 (zh) | 2011-07-26 | 2012-07-26 | 9‑氨基甲基取代的四环素类化合物 |
PCT/CN2012/001001 WO2013013505A1 (zh) | 2011-07-26 | 2012-07-26 | 9-氨基甲基取代的四环素类化合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
CN103717571A CN103717571A (zh) | 2014-04-09 |
CN103717571B true CN103717571B (zh) | 2016-01-13 |
CN103717571B8 CN103717571B8 (zh) | 2017-05-17 |
Family
ID=47600513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280037036.6A Active CN103717571B8 (zh) | 2011-07-26 | 2012-07-26 | 9‑氨基甲基取代的四环素类化合物 |
Country Status (18)
Country | Link |
---|---|
US (1) | US9365499B2 (zh) |
EP (1) | EP2738156B1 (zh) |
JP (1) | JP5792902B2 (zh) |
KR (1) | KR101732084B1 (zh) |
CN (1) | CN103717571B8 (zh) |
BR (1) | BR112014001798B1 (zh) |
CA (1) | CA2842838C (zh) |
DK (1) | DK2738156T3 (zh) |
ES (1) | ES2664516T3 (zh) |
HK (1) | HK1191931A1 (zh) |
HR (1) | HRP20180444T1 (zh) |
HU (1) | HUE036696T2 (zh) |
LT (1) | LT2738156T (zh) |
NO (1) | NO2738156T3 (zh) |
PL (1) | PL2738156T3 (zh) |
PT (1) | PT2738156T (zh) |
SI (1) | SI2738156T1 (zh) |
WO (1) | WO2013013505A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017219994A1 (zh) * | 2016-06-22 | 2017-12-28 | 山东亨利医药科技有限责任公司 | 9-氨基甲基取代的四环素类化合物的晶型及其制备方法 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
NZ587051A (en) | 2008-01-04 | 2012-12-21 | Intellikine Llc | Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase) |
CN103648499B (zh) | 2011-01-10 | 2017-02-15 | 无限药品股份有限公司 | 用于制备异喹啉酮的方法及异喹啉酮的固体形式 |
PT2738156T (pt) | 2011-07-26 | 2018-03-28 | Kbp Biosciences Usa Inc | Compostos de tetraciclina substituídos por 9-aminometil |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
CN103073481A (zh) * | 2013-02-06 | 2013-05-01 | 上海药明康德新药开发有限公司 | 一种4-氮杂螺[2.4]庚烷盐酸盐的制备方法 |
US9580758B2 (en) | 2013-11-12 | 2017-02-28 | Luc Montagnier | System and method for the detection and treatment of infection by a microbial agent associated with HIV infection |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
CN105384673B (zh) * | 2015-11-09 | 2017-11-14 | 南京富润凯德生物医药有限公司 | 3‑氟代‑氮杂环丁烷衍生物的合成方法 |
WO2017223422A1 (en) | 2016-06-24 | 2017-12-28 | Infinity Pharmaceuticals, Inc. | Combination therapies |
CN106883138B (zh) * | 2017-03-01 | 2018-07-10 | 郑州大学第一附属医院 | 老虎素的制备方法 |
CA3095102A1 (en) * | 2018-04-06 | 2019-10-10 | Paratek Pharmaceuticals, Inc. | Process for making sarecycline hydrochloride |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1649582A (zh) * | 2002-03-08 | 2005-08-03 | 帕拉特克药品公司 | 氨基-甲基取代的四环素类化合物 |
CN101759604A (zh) * | 2008-09-12 | 2010-06-30 | 山东轩竹医药科技有限公司 | 胍基取代的四环素衍生物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03000055A (es) | 2000-07-07 | 2003-07-14 | Tufts College | Compuestos de monociclina sustituidos en posicion 9.. |
US20030012352A1 (en) * | 2001-07-13 | 2003-01-16 | Serdar Kiykioglu | Application of metering tones to a DSL and voice communications network |
AU2003287218C1 (en) * | 2002-10-24 | 2010-07-15 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
WO2004064728A2 (en) | 2003-01-16 | 2004-08-05 | Paratek Pharmaceuticals, Inc. | Use of specific tetracycline compounds in therapy |
AU2004259659B2 (en) * | 2003-07-09 | 2011-11-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
SI2109602T1 (sl) * | 2006-12-21 | 2014-06-30 | Paratek Pharmaceuticals, Inc. | Derivati tetraciklina za zdravljenje bakterijskih, virusnih in parazitskih infekcij |
PT2738156T (pt) | 2011-07-26 | 2018-03-28 | Kbp Biosciences Usa Inc | Compostos de tetraciclina substituídos por 9-aminometil |
-
2012
- 2012-07-26 PT PT128177748T patent/PT2738156T/pt unknown
- 2012-07-26 EP EP12817774.8A patent/EP2738156B1/en active Active
- 2012-07-26 DK DK12817774.8T patent/DK2738156T3/en active
- 2012-07-26 CA CA2842838A patent/CA2842838C/en active Active
- 2012-07-26 LT LTEP12817774.8T patent/LT2738156T/lt unknown
- 2012-07-26 KR KR1020147005035A patent/KR101732084B1/ko active IP Right Grant
- 2012-07-26 SI SI201231256T patent/SI2738156T1/en unknown
- 2012-07-26 JP JP2014521914A patent/JP5792902B2/ja active Active
- 2012-07-26 ES ES12817774.8T patent/ES2664516T3/es active Active
- 2012-07-26 BR BR112014001798-0A patent/BR112014001798B1/pt active IP Right Grant
- 2012-07-26 WO PCT/CN2012/001001 patent/WO2013013505A1/zh active Application Filing
- 2012-07-26 NO NO12817774A patent/NO2738156T3/no unknown
- 2012-07-26 PL PL12817774T patent/PL2738156T3/pl unknown
- 2012-07-26 HU HUE12817774A patent/HUE036696T2/hu unknown
- 2012-07-26 CN CN201280037036.6A patent/CN103717571B8/zh active Active
- 2012-07-26 US US14/234,420 patent/US9365499B2/en active Active
-
2014
- 2014-06-06 HK HK14105301.7A patent/HK1191931A1/zh unknown
-
2018
- 2018-03-15 HR HRP20180444TT patent/HRP20180444T1/hr unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1649582A (zh) * | 2002-03-08 | 2005-08-03 | 帕拉特克药品公司 | 氨基-甲基取代的四环素类化合物 |
CN101759604A (zh) * | 2008-09-12 | 2010-06-30 | 山东轩竹医药科技有限公司 | 胍基取代的四环素衍生物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017219994A1 (zh) * | 2016-06-22 | 2017-12-28 | 山东亨利医药科技有限责任公司 | 9-氨基甲基取代的四环素类化合物的晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
PL2738156T3 (pl) | 2018-06-29 |
DK2738156T3 (en) | 2018-03-26 |
EP2738156A4 (en) | 2015-01-07 |
HK1191931A1 (zh) | 2014-08-08 |
CN103717571B8 (zh) | 2017-05-17 |
PT2738156T (pt) | 2018-03-28 |
JP5792902B2 (ja) | 2015-10-14 |
WO2013013505A1 (zh) | 2013-01-31 |
HRP20180444T1 (hr) | 2018-05-04 |
NO2738156T3 (zh) | 2018-06-02 |
KR101732084B1 (ko) | 2017-05-02 |
KR20140050694A (ko) | 2014-04-29 |
CA2842838A1 (en) | 2013-01-31 |
CN103717571A (zh) | 2014-04-09 |
ES2664516T3 (es) | 2018-04-19 |
EP2738156A1 (en) | 2014-06-04 |
HUE036696T2 (hu) | 2018-07-30 |
JP2014529342A (ja) | 2014-11-06 |
SI2738156T1 (en) | 2018-05-31 |
US20140179638A1 (en) | 2014-06-26 |
CA2842838C (en) | 2017-04-25 |
LT2738156T (lt) | 2018-05-25 |
EP2738156B1 (en) | 2018-01-03 |
US9365499B2 (en) | 2016-06-14 |
BR112014001798B1 (pt) | 2021-07-27 |
BR112014001798A2 (pt) | 2017-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103717571B (zh) | 9-氨基甲基取代的四环素类化合物 | |
CN103635456B (zh) | 替加环素衍生物 | |
EP2725031B1 (en) | C-glycoside derivatives | |
WO2013071039A1 (en) | Macrocyclic compounds for inhibition of inhibitors of apoptosis | |
CA3113463A1 (en) | Nitroxoline prodrug and use thereof | |
EP3798220B1 (en) | P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof | |
CN103396396B (zh) | 胺基烷酰克林沙星及其应用 | |
CN107400142B (zh) | 一种硼酸和硼酸酯类化合物及其应用 | |
CN109776510A (zh) | 一种n-取代咪唑甲酸酯类衍生物及其用途 | |
JP2021535909A (ja) | 高活性stingタンパク質アゴニスト化合物 | |
WO2018086243A1 (zh) | 氟硼二吡咯衍生物及其制备方法和在医药上的应用 | |
CN101613386B (zh) | 藤黄酸环合类似物及其制备方法和应用 | |
CN113861161A (zh) | 一种芳基并芳杂环衍生物及其制备方法和用途 | |
CN110964078B (zh) | 具有抗肺癌作用的常春藤皂苷元类化合物h-x及其制备方法和应用 | |
CN109796519A (zh) | 一类甾体化合物及其应用 | |
CN114149395A (zh) | 一种苯并环戊烯酮衍生物、其制备方法及医药用途 | |
CN103709102A (zh) | 含有螺环的截短侧耳素类抗生素 | |
CN116583303A (zh) | 雷公藤甲素缀合物和其用途 | |
CN1125065C (zh) | 苯并[g]喹啉衍生物 | |
CA2605919A1 (en) | Hydromorphone polymorphs | |
WO2024099434A1 (zh) | 葫芦脲类化合物及其医药用途 | |
EP4137480A1 (en) | Amino acid derivative containing non-steroidal anti-inflammatory drug structure, preparation method therefor and application thereof | |
CN107200725B (zh) | 稠杂环类衍生物、其制备方法及其在医药上的应用 | |
CN101684080B (zh) | 含有甲酰肼基的四环素化合物 | |
CN117427176A (zh) | 一种药物偶联物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1191931 Country of ref document: HK |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: National priority Correct: 201110222016.3 2011.07.26 CN Number: 02 Volume: 32 |
|
CI01 | Publication of corrected invention patent application | ||
CI03 | Correction of invention patent |
Correction item: National priority Correct: 201110222016.3 2011.07.26 CN Number: 02 Page: The title page Volume: 32 |
|
CI03 | Correction of invention patent | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1191931 Country of ref document: HK |